Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program

Cancer

Volumn 121, Issue 18, 2015, Pages 3221-3229

  Chiu, Han Mo ^a   Chen, Sam Li Sheng ^b   Yen, Amy Ming Fang ^b   Chiu, Sherry Yueh Hsia ^c   Fann, Jean Ching Yuan ^d   Lee, Yi Chia ^a   Pan, Shin Liang ^a   Wu, Ming Shiang ^a   Liao, Chao Sheng ^e   Chen, Hsiu Hsi ^f   Koong, Shin Lan ^g   Chiou, Shu Ti ^g,h  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d KAINAN UNIVERSITY   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g Ministry of Health and Welfare   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

colorectal cancer; fecal immunochemical testing; mortality reduction; population based screening

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GOVERNMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; SIGMOIDOSCOPY; TAIWANESE; TUMOR INVASION; VERY ELDERLY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; EPIDEMIOLOGY; MASS SCREENING; MIDDLE AGED; MORTALITY; OCCULT BLOOD; PROCEDURES; TAIWAN;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES; TAIWAN;

EID: 84940961410     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29462     Document Type: Article

References (26)

1. Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O,. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348: 1467-1471.
3. Mandel JS, Bond JH, Church TR, et al., Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328: 1365-1371.
4. Faivre J, Dancourt V, Lejeune C, et al., Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004; 126: 1674-1680.
5. Costantini AS, Martini A, Puliti D, et al., Colorectal cancer mortality in two areas of Tuscany with different screening exposures. J Natl Cancer Inst. 2008; 100: 1818-1821.
6. Smith A, Young GP, Cole SR, Bampton P,. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006; 107: 2152-2159.
7. Park DI, Ryu S, Kim YH, et al., Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010; 105: 2017-2025.
8. Hol L, van Leerdam ME, van Ballegooijen M, et al., Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010; 59: 62-68.
9. van Rossum LG, van Rijn AF, Laheij RJ, et al., Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008; 135: 82-90.
10. Hol L, Wilschut JA, van Ballegooijen M, et al., Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009; 100: 1103-1110.
11. Benson VS, Atkin WS, Green J, et al,; International Colorectal Cancer Screening Network. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network. Int J Cancer. 2012; 130: 2961-2973.
12. Sung JJ, Lau JY, Goh KL, Leung WK,. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6: 871-876.
13. Yang KC, Liao CS, Chiu YH, Yen AM, Chen TH,. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen. 2006; 13 (suppl 1): S8-S13.
14. Chen TH, Chiu YH, Luh DL, et al., Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer. 2004; 100: 1734-1743.
15. Taiwanese Bureau of Health Promotion. Cancer control and prevention. http://www.hpa.gov.tw/BHPNet/English/ClassShow.aspx?No=201401280006. Accessed May 1, 2015.
16. Chen LS, Liao CS, Chang SH, Lai HC, Chen TH,. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen. 2007; 14: 191-199.
17. Hamilton SR, Vogelstein B, Kudo S, et al., Tumours of the colon and rectum. In:, Hamilton SR, Aaltonen LA, eds. World Health Organization Classifications of Tumors: Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC; 2000.
18. Taiwan Cancer Registry. http://tcr.cph.ntu.edu.tw/uploadimages/Y92-ALL.pdf. Accessed July 5, 2013.
19. Duffy SW, Cuzick J, Tabar L, et al., Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Stat Soc Ser C Appl Stat. 2002; 51: 235-243.
20. Tabar L, Yen MF, Vitak B, et al., Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003; 361: 1405-1410.
21. Wu JC, Anttila A, Yen AM, et al., Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res Treat. 2010; 121: 671-678.
22. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E,. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007: CD001216.
23. International Cancer Screening Network. Inventory of colorectal cancer screening activities in ICSN countries, May 2008. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html. Accessed July 5, 2013.
24. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee. The Australian bowel cancer screening pilot and beyond: final evaluation report. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/9C0493AFEB3FD33CCA257D720005C9F2/-File/final-eval.pdf. Accessed July 5, 2013.
25. Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S,. Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol. 2008; 103: 974-981.
26. Chiu HM, Lee YC, Tu CH, et al., Association between early-stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013; 11: 832-838.